Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%.
Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for …
Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for …
[HTML][HTML] Proteomics-driven biomarkers in Pancreatic Cancer
Pancreatic cancer is a devastating disease that has a grim prognosis, highlighting the need
for improved screening, diagnosis, and treatment strategies. Currently, the sole biomarker …
for improved screening, diagnosis, and treatment strategies. Currently, the sole biomarker …
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Simple Summary Pancreatic cancer (PCa) is a highly aggressive and deadly form of cancer
with a low five-year survival rate. This paper explores the role of pharmacologic …
with a low five-year survival rate. This paper explores the role of pharmacologic …
Role of CA 19.9 in the management of resectable pancreatic cancer: state of the art and future perspectives
A Coppola, V La Vaccara, T Farolfi, M Fiore… - Biomedicines, 2022 - mdpi.com
Background: Surgery still represents the gold standard of treatment for resectable pancreatic
ductal adenocarcinoma (PDAC). Neoadjuvant treatments (NAT), currently proposed for …
ductal adenocarcinoma (PDAC). Neoadjuvant treatments (NAT), currently proposed for …
[HTML][HTML] MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
LA Bravo-Vázquez, N Frías-Reid… - Translational …, 2023 - Elsevier
MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two relevant classes of non-
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …
The integration of Metabolomics with other Omics: insights into understanding prostate Cancer
EP Resurreccion, K Fong - Metabolites, 2022 - mdpi.com
Our understanding of prostate cancer (PCa) has shifted from solely caused by a few genetic
aberrations to a combination of complex biochemical dysregulations with the prostate …
aberrations to a combination of complex biochemical dysregulations with the prostate …
GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses
Y Zhang, J Yang, X Wang, X Li - Scientific Reports, 2021 - nature.com
Pancreatic adenocarcinoma (PAAD) is one of the most lethal malignant tumors in the world.
The GSE55643 and GSE15471 microarray datasets were downloaded to screen the …
The GSE55643 and GSE15471 microarray datasets were downloaded to screen the …
Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma
S Akrami, A Tahmasebi, A Moghadam… - Computers in Biology …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the most death-dealing tumors, with a
tremendously poor prognosis. Here, we, through interrogation of mRNA and protein data …
tremendously poor prognosis. Here, we, through interrogation of mRNA and protein data …
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
EM Trifylli, AG Kriebardis, E Koustas… - International Journal of …, 2024 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies worldwide,
while it persists as the fourth most prevalent cause of cancer-related death in the United …
while it persists as the fourth most prevalent cause of cancer-related death in the United …
Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies
Pituitary neuroendocrine tumors (PitNETs) are the second most common type of intracranial
neoplasia. Since their manifestation usually causes hormone hypersecretion, effective …
neoplasia. Since their manifestation usually causes hormone hypersecretion, effective …